Insider Transactions in Q2 2021 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 07
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-8.52%
|
$1,950,000
$39.66 P/Share
|
Jun 07
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
May 11
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-2.17%
|
$2,150,000
$43.54 P/Share
|
May 11
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
May 05
2021
|
Jean Pierre Bizzari |
BUY
Grant, award, or other acquisition
|
Direct |
5,230
+5.64%
|
-
|
May 05
2021
|
Bernadette Connaughton |
BUY
Grant, award, or other acquisition
|
Direct |
5,230
+14.04%
|
-
|
May 05
2021
|
James M Daly |
BUY
Grant, award, or other acquisition
|
Direct |
5,230
+16.62%
|
-
|
May 05
2021
|
Jeffrey William Henderson |
BUY
Grant, award, or other acquisition
|
Direct |
5,230
+9.01%
|
-
|
May 05
2021
|
Connie Matsui |
BUY
Grant, award, or other acquisition
|
Direct |
5,230
+2.39%
|
-
|
May 05
2021
|
Matthew L. Posard |
BUY
Grant, award, or other acquisition
|
Direct |
5,230
+3.9%
|
-
|
May 03
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,311
+7.78%
|
$124,421
$11.29 P/Share
|
Apr 14
2021
|
Kenneth J Kelley Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.71%
|
$225,000
$45.0 P/Share
|
Apr 05
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-8.52%
|
$2,100,000
$42.55 P/Share
|
Apr 05
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
Apr 01
2021
|
Elaine D Sun SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,059
-22.45%
|
$170,478
$42.43 P/Share
|
Apr 01
2021
|
Elaine D Sun SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,196
+36.06%
|
-
|
Apr 01
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
28,689
-9.9%
|
$1,204,938
$42.45 P/Share
|
Apr 01
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
28,689
+15.92%
|
$315,579
$11.29 P/Share
|